Intravenous infusion of mesenchymal stem cells promotes functional recovery in a model of chronic spinal cord injury
- 1 October 2016
- journal article
- research article
- Published by Elsevier in Neuroscience
- Vol. 335, 221-231
Abstract
No abstract availableKeywords
Funding Information
- JSPS KAKENHI (26462213, 24890181, 25462227, 25462226, 16K10794)
- AMED Translational Research Network Program
- RR&D Service of U.S. Department of Veterans Affairs (B7335R, B9260L)
- National Multiple Sclerosis Society (RG2135)
- Connecticut (CT) Stem Cell Research Program (12-SCB-Yale-05)
This publication has 52 references indexed in Scilit:
- A Systematic Review of Cellular Transplantation Therapies for Spinal Cord InjuryJournal of Neurotrauma, 2011
- Transplantation of Specific Human Astrocytes Promotes Functional Recovery after Spinal Cord InjuryPLOS ONE, 2011
- Pericytes Control Key Neurovascular Functions and Neuronal Phenotype in the Adult Brain and during Brain AgingNeuron, 2010
- Recovery of motoneuron and locomotor function after spinal cord injury depends on constitutive activity in 5-HT2C receptorsNature Medicine, 2010
- Therapeutic Benefits by Human Mesenchymal Stem Cells (hMSCs) and Ang-1 Gene-Modified hMSCs after Cerebral IschemiaJournal of Cerebral Blood Flow & Metabolism, 2007
- Mesenchymal Stem Cells Derived from Peripheral Blood Protects against IschemiaJournal of Neurotrauma, 2007
- Remyelination of the injured spinal cord2007
- Neural differentiation potential of peripheral blood- and bone-marrow-derived precursor cellsBrain Research, 2006
- Delayed Nogo receptor therapy improves recovery from spinal cord contusionAnnals of Neurology, 2006
- Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemiaBrain, 2006